Cargando…

Sirolimus-Eluting Stents vs Uncoated Stents for the Treatment of Proximal Left Anterior Descending Coronary Artery Stenosis

Sirolimus-eluting stents (SES) have demonstrated low incidence of target vessel revascularizations in several anatomic scenarios, including proximal left anterior descending coronary artery (pLAD) lesions. The aim of present study was to compare the efficacy of SES with bare metal stents (BMS) for t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valencia, José, Mainar, Vicente, Bordes, Pascual, Berenguer, Alberto, Ruiz-Nodar, Juan Miguel, Pineda, Javier, Gomez, Silvia, Sogorb, Francisco, Caturla, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Master Publishing Group 2007
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614659/ https://www.ncbi.nlm.nih.gov/pubmed/23675052

Ejemplares similares

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
por: Ouyang, Hang, et al.
Publicado: (2021)

Everolimus-eluting stents versus sirolimus-eluting stents in patients with cardiac allograft vasculopathy
por: Hawranek, Michał, et al.
Publicado: (2021)

Sirolimus-eluting coronary stents: a review
por: Abizaid, Alexandre
Publicado: (2007)

Comparisons of the Effects of Stent Eccentricity on the Neointimal Hyperplasia between Sirolimus-Eluting Stent versus Paclitaxel-Eluting Stent
por: Kim, Byeong-Keuk, et al.
Publicado: (2010)

Complete Fracture of Sirolimus-Eluting Stent in a Saphenous Vein Graft to Left Anterior Descending Artery
por: Yoo, Sun Hong, et al.
Publicado: (2009)

Two-year Clinical Outcomes of Patients with Long Segments Drug-Eluting Stents: Comparison of Sirolimus-Eluting Stent with Paclitaxel-Eluting Stent
por: Kim, Ung, et al.
Publicado: (2011)

Drug eluting stents: Focus on Cypher™ sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions
por: Chieffo, Alaide, et al.
Publicado: (2007)

Two-Year Results of an Open-Label Randomized Comparison of Everolimus-Eluting Stents and Sirolimus-Eluting Stents
por: Velders, Matthijs A., et al.
Publicado: (2013)

Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
por: Jafaripour, Iraj, et al.
Publicado: (2023)

Sirolimus-eluting airway stent reduces profibrotic Th17 cells and inhibits laryngotracheal stenosis
por: Motz, Kevin M., et al.
Publicado: (2023)

Correction: Two-Year Results of an Open-Label Randomized Comparison of Everolimus-Eluting Stents and Sirolimus-Eluting Stents
por: Velders, Matthijs A., et al.
Publicado: (2013)

Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes
por: Kakizaki, Ryota, et al.
Publicado: (2020)

Case series of coronary artery aneurysms after Everolimus eluting stent implantation and comparison with Sirolimus eluting stents
por: Sharma, Raghav, et al.
Publicado: (2022)

Extensive Late-Acquired Incomplete Stent Apposition After Sirolimus-Eluting Stent Implantation
por: Choi, Hyun-Chul, et al.
Publicado: (2010)

Late Thrombosis of Sirolimus-Eluting Stent: A Multifactorial Problem
por: Kranjec, Igor, et al.
Publicado: (2009)

Long-term effectiveness and safety of sirolimus drug-eluting stents
por: Bikkina, Mahesh, et al.
Publicado: (2011)

Impact of diabetes on clinical outcomes after revascularization with the dual therapy CD34 antibody‐covered sirolimus‐eluting Combo stent and the sirolimus‐eluting Orsiro stent
por: Jakobsen, Lars, et al.
Publicado: (2022)

Reduction of In-Stent Restenosis and Inflammation with One Stent: New Concept of Sirolimus and Ascorbic Acid-Eluting Coronary Stent
por: Ryu, JiWung, et al.
Publicado: (2021)

Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents
por: Kim, J-S, et al.
Publicado: (2009)

A Case of Stent Thrombosis Occurred at 5 Years after Sirolimus-Eluting Stent Implantation
por: Kim, Su A, et al.
Publicado: (2011)

The different features of angiographic peri‐stent contrast staining after implantation of sirolimus‐eluting stents
por: Kageyama, Michiya, et al.
Publicado: (2017)

Elastic stent recoil in coronary total occlusions: Comparison of durable‐polymer zotarolimus eluting stent and ultrathin strut bioabsorbable‐polymer sirolimus eluting stent
por: Improta, Riccardo, et al.
Publicado: (2021)

Five‐Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus‐Eluting Stents Versus Durable Polymer Everolimus‐Eluting Stents
por: Iglesias, Juan F., et al.
Publicado: (2019)

Multiple Sequential Complications After Sirolimus-Eluting Stent Implantation: Very Late Stent Thrombosis, Stent Fracture, In-Stent Restenosis, and Peri-Stent Aneurysm
por: Seol, Sang-Hoon, et al.
Publicado: (2009)

Randomized clinical trial comparing abluminal biodegradable polymer sirolimus-eluting stents with durable polymer sirolimus-eluting stents: Nine months angiographic and 5-year clinical outcomes
por: Zhang, Haijun, et al.
Publicado: (2016)

Impact of acute coronary syndrome on clinical outcomes after revascularization with the dual‐therapy CD34 antibody‐covered sirolimus‐eluting Combo stent and the sirolimus‐eluting Orsiro stent
por: Jakobsen, Lars, et al.
Publicado: (2022)

Vascular Responses to First-Generation Sirolimus-Eluting Stents and Bare-Metal Stents Beyond 10 Years
por: Hada, Masahiro, et al.
Publicado: (2021)

Biodegradable polymer-coated thin strut sirolimus-eluting stent versus durable polymer-coated everolimus-eluting stent in the diabetic population
por: Gasior, Pawel, et al.
Publicado: (2021)

Very Late Stent Thrombosis 42 Months after Implantation of Sirolimus-Eluting Stent and Discontinuation of Antiplatelet Therapy
por: Sibbing, Dirk, et al.
Publicado: (2009)

Efficacy and safety of sirolimus-eluting stents versus bare-metal stents in coronary artery disease patients with diabetes
por: Jing, Juehua
Publicado: (2014)

The Ultimaster Biodegradable-Polymer Sirolimus-Eluting Stent: An Updated Review of Clinical Evidence
por: Chisari, Alberto, et al.
Publicado: (2016)

Early Restenosis of Sirolimus-eluting Stent: An Unusual Case of a Hyperthyroid Patient
por: Shabbir, Syeda Javeria, et al.
Publicado: (2019)

Unrestricted use of polymer-free sirolimus eluting stents in routine clinical practice
por: Krackhardt, Florian, et al.
Publicado: (2020)

Performance evaluation of biodegradable polymer sirolimus and ascorbic acid eluting stent systems
por: Jo, Won-Il, et al.
Publicado: (2022)

Early-Period Coronary Aneurysm Formation After Sirolimus-Eluting Stent Implantation
por: Kaya, Cihad, et al.
Publicado: (2023)

Proximal Left Anterior Descending Artery Treatment Using a Bioresorbable Polymer Coating Sirolimus‐Eluting Stent: Real‐World Outcomes From the Multicenter Prospective e‐Ultimaster Registry
por: Codner, Pablo, et al.
Publicado: (2019)

Open-labeled randomized controlled trial to evaluate the 1-year clinical outcomes of polymer-free sirolimus-eluting coronary stents as compared with biodegradable polymer-based sirolimus-eluting coronary stents
por: Viswanathan, Sunitha, et al.
Publicado: (2018)

A Randomized Controlled Trial Comparing BioMime Sirolimus-Eluting Stent With Everolimus-Eluting Stent: Two-Year Outcomes of the meriT-V Trial
por: Abizaid, Alexandre, et al.
Publicado: (2023)

Extremely late stent thrombosis after more than 7 years (2691 days) of sirolimus-eluting stent implantation
por: Demirci, Deniz, et al.
Publicado: (2018)

Correction to: Proximal Left Anterior Descending Artery Treatment Using a Bioresorbable Polymer Coating Sirolimus‐Eluting Stent: Real‐World Outcomes From the Multicenter Prospective e‐Ultimaster Registry
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a5e3ljh3dri21065up0cie36b4